
Clinical impact of transesophageal echocardiography in patients with stroke without clinical evidence of cardiovascular sources of emboli
2001; Sociedade Brasileira de Cardiologia (SBC); Volume: 76; Issue: 6 Linguagem: Inglês
10.1590/s0066-782x2001000600003
ISSN1678-4170
AutoresSolange Bernardes Tatani, Márcia Maiumi Fukujima, João Augusto Costa Lima, Luiz Darcy Cortez Ferreira, Cláudia G. Monaco Ghefter, Gilmar Fernandes do Prado, Zara Babayan, Lyamara Apostólico de Azevedo,
Tópico(s)Aortic Thrombus and Embolism
ResumoThe purpose of this study is to evaluate the impact of transeophageal echocardiography on management of patients at low-risk for cardiogenic embolism to prevent new potential cardiovascular sources of emboli.We studied 69 patients with ischemic stroke at low-risk for cardiogenic embolism. Transeophageal echocardiography was performed to access: left atrium enlargement; communication or aneurysm of the interatrial septum; patent foramen ovale; spontaneous echo contrast or intracavitary thrombi; the presence of intraaortic atherosclerotic plaques or thrombi; significant valvar morphologic alteration or dysfunction; left ventricle enlargement, hypertrophy, or contractile abnormality. Transesophageal echocardiography altered clinical management, and we adopted anticoagulant therapy or another procedure apart from the use of acetylsalicylic acid.Transeophageal echocardiography detected at least one abnormality in 40 cases (58%). Clinical conduct was adjusted after the performance of transesophageal echocardiography in 11 patients (15.9%); anticoagulation was added in 10 cases and surgical correction in one patient.Transeophageal echocardiography was a very useful tool in the secondary prevention for stroke in patients at low risk for cardiogenic embolism.
Referência(s)